Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 15.57 CNY -0.19% Market Closed
Market Cap: 14B CNY
Have any thoughts about
Zhejiang Jiuzhou Pharmaceutical Co Ltd?
Write Note

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Other Long-Term Assets
ÂĄ8.1m
CAGR 3-Years
-27%
CAGR 5-Years
-24%
CAGR 10-Years
10%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Long-Term Assets
ÂĄ215.7m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
8%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Long-Term Assets
ÂĄ702.3m
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Long-Term Assets
ÂĄ928.6m
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Long-Term Assets
ÂĄ84.9m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
8.1m CNY

Based on the financial report for Jun 30, 2024, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 8.1m CNY.

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
10%

Over the last year, the Other Long-Term Assets growth was -78%. The average annual Other Long-Term Assets growth rates for Zhejiang Jiuzhou Pharmaceutical Co Ltd have been -27% over the past three years , -24% over the past five years , and 10% over the past ten years .

Back to Top